These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 4277856)

  • 1. [Influence of age and menopause duration on the excretion of steroid hormones in precancerous conditions and cancer of the breast].
    Bogdanova AG
    Vopr Onkol; 1974 Oct; 20(7):13-8. PubMed ID: 4277856
    [No Abstract]   [Full Text] [Related]  

  • 2. [Excretion of adrenal cortex hormones in precancerous processes and uterine cancer].
    Bogdanova AG; Mezinova NN
    Vopr Onkol; 1973; 19(7):27-31. PubMed ID: 4272619
    [No Abstract]   [Full Text] [Related]  

  • 3. The relationship of urinary androgen metabolites to breast diseases including carcinoma.
    Wetchler BB; McCarrick J; Allerhand J; Dreiling DA
    Mt Sinai J Med; 1974; 41(5):682-6. PubMed ID: 4278335
    [No Abstract]   [Full Text] [Related]  

  • 4. The excretion of 17-ketosteroids in patients suffering from mastopathia fibrocystica and mammary carcinomas.
    Görlich M; Heise E; Pradja N; Hindy I
    Arch Geschwulstforsch; 1975; 45(7):648-57. PubMed ID: 132149
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Investigation of 17-ketosteriod excretion in mastopathia and premenopausal breast cancer.
    Hindy I; Prajda N; Tapolcsányi L; Sellei C; Eckhardt S
    Arch Geschwulstforsch; 1975; 45(5):453-6. PubMed ID: 129041
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The urinary dehydroepiandrosterone, androsterone and etiocholanolone excretion of healthy women and women with benign and malignant breast disease.
    Ivanović S; Agbaba D; Zivanov-Stakić D; Konstantinović I
    J Clin Pharm Ther; 1990 Jun; 15(3):213-9. PubMed ID: 2142165
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Basic results of a study of bilateral adrenalectomy for advanced breast cancer. Urinary steroids and related data in 148 patients.
    Sarfaty G; Pitt P; Tallis M
    Med J Aust; 1973 Nov; 2(19):877-81. PubMed ID: 4128906
    [No Abstract]   [Full Text] [Related]  

  • 8. High-resolution biomedical gas chromatography. Study of urinary steroid metabolite ratios of women with breast lesions using open-tubular glass capillary columns.
    Pfaffenberger CD; Malinak LR; Horning EC
    J Chromatogr; 1978 Oct; 158():313-30. PubMed ID: 721935
    [No Abstract]   [Full Text] [Related]  

  • 9. Urinary free cortisol, cortisone, cortisol sulfate, cortisone sulfate and 17-ketosteroids in breast cancer.
    Stancáková A; Klimesová Z
    Neoplasma; 1979; 26(2):205-13. PubMed ID: 157439
    [No Abstract]   [Full Text] [Related]  

  • 10. [On the metabolism of phosphates and sulfates of androsterone and epiandrosterone].
    Schubert K; Hobe G; Bacigalupo G
    Endokrinologie; 1966 Aug; 50(3):138-44. PubMed ID: 4232576
    [No Abstract]   [Full Text] [Related]  

  • 11. Hormonal influences in breast cancer.
    Forrest AP
    Proc R Soc Med; 1971 May; 64(5):509-16. PubMed ID: 4252687
    [No Abstract]   [Full Text] [Related]  

  • 12. Benign and malignant breast disease in South Wales: a study of urinary steroids.
    Cameron EH; Griffiths K; Gleave E; Stewart HJ; Forrest AP; Campbell H
    Br Med J; 1970 Dec; 4(5738):768-71. PubMed ID: 4250592
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Urinary androgen excretion and the etiology of breast cancer.
    Bulbrook RD
    J Natl Cancer Inst; 1972 Apr; 48(4):1039-42. PubMed ID: 5023673
    [No Abstract]   [Full Text] [Related]  

  • 14. [The level of follicle stimulating activity in precancer and cancer of the breast].
    Iskakova KI; Mezinova NN
    Vopr Onkol; 1973; 19(9):15-9. PubMed ID: 4788392
    [No Abstract]   [Full Text] [Related]  

  • 15. Urinary 17-ketosteroid fractions in young patients with breast cancer.
    Chiricuţă I; Frenkel Z; Muteanu S
    Endocrinologie; 1978; 16(2):135-7. PubMed ID: 150018
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Urinary estrogen excretion in preneoplastic breast diseases].
    Kozhnazarova IuS; Mezinova NN; Remizova MG; Ikhsanova ST
    Vopr Onkol; 1972; 18(10):23-6. PubMed ID: 4662530
    [No Abstract]   [Full Text] [Related]  

  • 17. [The mechanism of action of hydrocortisone administered by lumbar puncture in breast cancer].
    Bordiushkov IuN; Mindlin SS; Verkhovtseva AI
    Vopr Onkol; 1973; 19(9):19-23. PubMed ID: 4274750
    [No Abstract]   [Full Text] [Related]  

  • 18. Hormonal status of breast cancer. I. Thoretical basis for the analysis of steroid profile.
    Kodama M; Kodama T
    J Natl Cancer Inst; 1975 May; 54(5):1023-9. PubMed ID: 1127732
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hormonal status of cervical cancer.
    Kodama M; Kodama T; Totani R
    J Natl Cancer Inst; 1977 Jul; 59(1):41-7. PubMed ID: 875061
    [No Abstract]   [Full Text] [Related]  

  • 20. A comparison of urinary 17-hydroxycorticosteroid and 11-deoxy-17-oxosteroid excretion in obesity, in thyroid dysfunction and in early breast cancer.
    Sneddon A; Steel JM; Strong JA
    J Endocrinol; 1969 Feb; 43(2):48-9. PubMed ID: 4237784
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.